Pharmaceutical Company Negotiates Clinical Trial Agreements

A publicly traded pharmaceutical company negotiated clinical trial agreements in the U.S. in connection with a Phase III clinical trial for a novel small molecule therapeutic. Our firm represented the company in its negotiation.

The Faegre Drinker Biddle & Reath LLP website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Drinker Biddle & Reath LLP's cookies information for more details.